A Phase II Study of TLN-4601 in Patients With Glioblastoma Multiforme.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2010
At a glance
- Drugs Diazepinomicin (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 22 Dec 2009 Status changed from active, no longer recruiting to discontinued, based on information from a Thallion media release. The trial was discontinued to due the lack of efficacy demonstrated in an interim analysis of results from 20 patients.
- 30 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Aug 2009 New source identified and integrated (Memorial Sloan-Kettering Cancer Center).